Form 4: Treace Medical Concepts Executive Sean Scanlan Reports Share Transfer

Chief Innovation Officer of Treace Medical Concepts, Sean Scanlan, reports a transfer of shares due to a domestic relations order.

Summary

• Sean Scanlan, Chief Innovation Officer at Treace Medical Concepts, filed a Form 4 indicating a change in beneficial ownership.
• The transaction involved the disposal of 4,821 shares of common stock.
• This disposal was a result of a transfer of 20,000 shares to his former spouse as part of a domestic relations order.
• The reported transaction occurred on January 10, 2025.
• Following the transaction, Scanlan's direct ownership is reported as 225,253 shares, which includes 198,078 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to a personal matter of an executive, and does not indicate any positive or negative sentiment for the company's performance.

Industry Context

This is a standard SEC filing for changes in beneficial ownership by company insiders. Such filings are common and provide transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are a standard requirement for publicly traded companies in the United States.
• The reporting of share transfers due to domestic relations orders is not uncommon and is a normal part of executive disclosures.
• The level of detail provided in this filing is consistent with SEC requirements for Form 4 filings.

Stakeholder Impact

• The share transfer has a minor impact on the total shares outstanding, but is not expected to significantly affect shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Share Transfer, Domestic Relations Order, Treace Medical Concepts, TMCI, Sean Scanlan, Chief Innovation Officer, Restricted Stock Units